Background. Vestibular migraine (VM) is one of the most common underdiagnosed disorders. We aimed to study the clinical characteristics of VM patients who were referred to a neurologyheadache unit by otolaryngology after exclusion of peripheral causes of vertigo.
Introduction
Vestibular migraine (VM) is the second most common cause of vertigo after benign paroxysmal positional vertigo [1] ; it affects 1% of the general population [2] . Although VM is a frequent cause of recurrent vertigo/ dizziness episodes, it is still not recognized adequately when the patients' main complaints are vestibular symptoms but not headache. Misdiagnosis increases when vestibular symptoms and headache do not occur simultaneously. The prevalence of migraine is increased among patients with unclassified vertigo. Definite diagnostic criteria were not established for a long time, and different names were used to define migraine patients with vestibular symptoms such as migrainous vertigo, migraine associated vertigo, and vertiginous migraine. Benign paroxysmal positional vertigo is three times more common in migraineurs and increases diagnostic ambiguity [3] . In 2013, in the appendix of the new International Classification of Headache Disorders 3 beta version (ICHD-3 beta), diagnostic criteria for VM were published for the first time [4] . However, vestibular migraine is still underrecognized, particularly by clinicians other than headache specialists.
There is heterogeneity in clinical features of VM, in addition to the various expressions of vestibular symptoms. Vestibular symptoms may initiate before, during, or after the headache [5] or vestibular symptoms, and the headache may be completely independent. Patients may have vestibular symptoms during headache-free days [6] . One of the main problems is that the vestibular symptoms do not exactly match well-known external vertigo definitions, and imaging and auditory tests generally do not reveal a significant pathology.
The primary objective of the study is to define the clinical characteristics of symptoms in a subgroup of VM. This subgroup consists of patients with long-standing vestibular symptoms who were diagnosed with VM when headache specialist consultation was requested from otolaryngology as a peripheral cause of vertigo was absent. Secondary objectives are to evaluate the trigger factors, accompanying diseases, and the response to vestibular-suppressant medications and prophylactic migraine treatment.
Methods

Study Design
Patients referred to the headache outpatient unit by an otolaryngologist (NG) upon exclusion of peripheral causes of vertigo (normal vestibular and hearing tests, limited response to vestibular suppressants and longstanding symptoms) were retrospectively reviewed. Patients were evaluated/diagnosed and followed by a headache specialist (HB) using a detailed questionnaire for headache and vestibular symptoms for VM patients. One hundred and one VM patients between 2014 and 2015 were enrolled in the study.
Inclusion criteria were 1) age between 18 and 65 years; 2) diagnosis of vestibular migraine according to ICHD-3 beta (A1.6.5); and 3) normal findings on the Dix Hallpike maneuver and normal hearing and caloric test results. Exclusion criteria were 1) existence of another cause of vertigo (such as Meniere's disease, vestibular neuritis, benign paroxysmal positional vertigo, vertebrobasilar insufficiency, etc.); 2) any other neurological disease; 3) abnormal magnetic resonance imaging (MRI) findings; 4) history of alcohol or drug abuse; 5) other primary and secondary headaches; 6) dizziness associated with chronic anxiety without presence of migraine; 7) history of head trauma; 8) past history of intracranial infections (e.g., meningitis, encephalitis, brain abscess). Demographic characteristics of the patients, ages at migraine and VM onset, features and duration of vestibular symptoms, the temporal relationship between headache and vestibular symptoms, migraine classification as episodic or chronic, presence of medication overuse headache, pain intensity based on visual analog scale (VAS), frequency of headache, presence of motion sickness in the history, family history of migraine, usage of vestibular-suppressant medications such as dimenhydrinate and betahistine and their efficacy, trigger factors, accompanying diseases, magnetic resonance imaging results, and medications used in preventive migraine treatment and their efficacy were evaluated. A regional ethics review board, according to the Helsinki Declaration, approved the study (E-16-751).
Statistical Analysis
Data analysis was carried out in the SPSS 15.0 for Windows software. Normalization of data was investigated by Kolmogorov-Smirnov test. Descriptive statistics were indicated as mean 6 standard deviation while categorical variables were reported as frequency and percentage values (%). The importance of the difference between the groups in terms of mean values was evaluated with a paired t test when there was a dependent variable between two related groups. Categorical variables were evaluated using Pearson's chi-square test. Statistical significance was assumed at a P value of less than 0.05.
Results
One hundred and nineteen patients, referred to the headache unit after exclusion of peripheral causes of vertigo by otolaryngology, who met the inclusion criteria were included in the study. Eighteen patients were excluded from the study. Nine patients had abnormal MRI findings (two patients had pontine infarcts, three patients had cerebellar infarcts, three patients had demyelinating lesions, and one patient had an intracranial mass), four patients had a history of head trauma in a car accident, two patients had a past history of meningitis, and three patients had vertebrobasilar insufficiency.
The mean age of the patients was 40.1 6 10.2 years. There was a clear female predominance; 86.1% of the patients were female whereas 13.9% were male. The mean age at migraine onset was 27.5 6 10.8 years.
The mean age at VM onset was 34.7 6 11.0 years. Body mass index (BMI) was between 18 and 25 in 63.3% of the patients, BMI was between 25 and 30 in 21.8%, and BMI was greater than 30 in 21.8%. The majority of the patients (62.4%) suffered from episodic migraine (EM), 11.9% had chronic migraine (CM), and 25.7% had CM and medication overuse headache (MOH). Only two patients suffered from migraine with visual aura symptoms. There was positive family history for migraine in 55.4% patients. Motion sickness was present in 47.5%.
Visual and Postural Motion Evoked Dizziness Symptoms in Vestibular Migraine
Headache days per month were 11.6 6 9.9. Mean VAS score before migraine prophylaxis was 7.16 1.7. Mean VAS score after preventive treatment was 4.7 6 1.1. There was a significant difference between VAS scores before and after the treatment (P < 0.001). Five patients denied any headache symptoms at first though they had trigger points (cervical paraspinal, trapezius), tenderness over greater occipital nerves (GONs), and pericranial muscle tenderness, but during follow-up, they also defined headache with migrainous features. The duration of vestibular symptoms was 5.4 6 5.2 years; 51.5% of the patients had a prior misdiagnosis of Meniere's disease. All of the patients described moderate to severe vestibular symptoms that interfered with their daily activities. The demographic and some of the clinical features of VM patients are summarized in Table 1 .
Patients defined vestibular symptoms as feeling the ground slipping from under their feet (40.6%), feeling like there is an earthquake or sensation of swaying (27.7%), sensation of rocking on a boat (26.7%), sensation of falling or sensation as if stepping on empty space (24.8%), feeling of being pushed from behind (19.8%), feeling of being pulled sideways (8.9%), feeling as if surroundings are spinning around (5.0%), and sensation of falling from a height (2.0%). One patient described her vestibular symptom as impaired depth perception on the right visual field that changes with eye and/or head movements. Descriptions of vestibular symptoms by patients are presented in Table 2 . Trigger points (cervical paraspinal and trapezius) were present in 64.4% of the patients. Eighty-three point two percent of the patients used vestibular-suppressant drugs; however, only in 12.9% were these drugs effective temporarily. Vestibular symptoms lasted seconds in 60.4% of the patients, lasted minutes in 32.7%, and lasted hours in 6.9%. Although vestibular symptoms lasted seconds, it occurred with every movement, especially head movement and visual stimuli, and continued for hours and sometimes even days. Therefore, the total period of the vestibular episode was longer. Fifty-two point five percent of the patients described vestibular symptoms as ictal, whereas in 24.8%, they were described as interictal, in 12.8% vestibular symptoms were described as both ictal and interictal, and in 9.9% they were described as daily. None of our patients had tinnitus or nystagmus.
The main factors and conditions that induce or aggravate vestibular symptoms were head/body motion (e.g., walking and turning head, 82.2%), moving visual stimuli (moving crowds, traffic, movie/TV/computer screen, 71.3%), passive motion (riding in a train/bus/car, standing on an escalator, 49.5%), and visually busy environments (shopping malls, supermarkets, 47.5%) ( Table 3) . Triggers for vestibular migraine attacks (Table 4) were sleep deprivation (62.4%), hunger or skipping meals (53.5%), stress (48.5%), menstruation (41.6%), infections (37.6%), seasonal weather changes (19.8%), cold and windy weather (17.8%), greasy and salty foods (12.9%), coffee and tea abuse (11.9%), high altitudes (5.9%), alcohol consumption (5.0%), and daily mineral water intake (4.0%). The principal accompanying diseases were sleep disorders (34.7%), depression (21.8%), anxiety (19.8%), hypertension (11.9%), thyroid dysfunction (8.9%), fibromyalgia (6.9%), insulin resistance and diabetes mellitus (6.9%), gastritis (5.0%), irritable bowel disease (4.0%), restless legs syndrome (4.0%), and asthma (3.0%). In 17.8% of the patients, brain MRI revealed nonspecific milimetric white matter lesions. Propranolol 40 to 80 mg (51.5%), duloxetine 60 mg (34.7%), topiramate 50 to 100 mg (23.8%), metoprolol 50 to 100 mg (18.8%), and amitriptyline 25 to 50 mg (17.8%) were the most common medications used for vestibular migraine prophylaxis. Valproic acid (750-1,000 mg) was also used in three patients. Trazodone 50 mg (9.9%), quetiapine 25 mg (6.9%), and mirtazapine 15 mg (2.0%) were other medications used for insomnia.
A greater than 50% decrease in the frequency of vestibular symptoms and headache was defined as treatment response. Patients were under monotherapy or polytherapy for migraine prophylaxis. In 86.1% of the patients, the frequency of vestibular symptoms was reduced by more than 50%, and in 11.9% vestibular symptoms were absent after two months of migraine prophylaxis. In 97.0% of the patients, migraine headache frequency was reduced by more than 50%, and 2.0% were headache-free after migraine prophylaxis.
Discussion
We presented clinical features of VM patients with longstanding vestibular symptoms for whom peripheral causes were excluded by otolaryngology. VM is more frequent in women, with a female to male ratio of up to 5:1 [2, 5, 7, 8] . VM usually follows the onset of migraine headache with a temporal delay [9] . There was an approximately seven-year delay between migraine onset and VM symptoms in our patients. As only two of our VM patients had migraine with aura, VM seems to develop in migraine without aura patients rather than migraine with aura patients, which is compatible with the previous reports [10] [11] [12] . Migraine headache may be masked by vestibular symptoms, as observed in a few patients in the presented study, or substituted by vertigo or dizziness attacks in postmenopausal woman [13] .
Patients are usually misdiagnosed with Meniere's disease by ear, nose, and throat specialists, even though VM affects five to 10 times more people in the general population than Meniere's disease [14] . Fifty-one point five percent of the patients in our study had a prior misdiagnosis of Meniere's disease. This fact points out that VM is still an underdiagnosed clinical entity, and it is not easily recognized in patients presenting with vertigo/ dizziness.
In VM, vestibular symptoms were expressed as "the ground slips away from under my feet," "feel like there is an earthquake," "swaying," "rocking on a boat," and "sensation as if stepping on empty space." The descriptions of the patients fit into dizziness rather than spontaneous internal or external vertigo. It is noteworthy that no falls or injury were reported by VM patients, even though they complained of the symptoms listed above.
Abnormal spatial orientation and perception of head motion have been shown in vestibular migraine. The patients become extremely sensitive to head motion and visual stimuli, leading to easily triggered vestibular symptoms [15] . Visually induced vestibular symptoms typically occur in so-called visually busy surroundings such as shopping malls, supermarkets, and traffic. Even though the term "visual vertigo" is used in patients who report visually induced vestibular symptoms, the symptoms constitute mainly of dizziness rather than classical rotational vertigo. In shopping malls where abundant visual stimuli entered to the patients' visual field, patients complained of dizziness. Vestibular symptoms were induced by positional head motion or looking at moving objects, and some patients described dizziness caused by eye movements. One of the typical aspects of vestibular symptoms was the induction or aggravation by daily head and/or body motion with no specific direction or position. Even if the attacks usually lasted seconds, they tended to occur with every head movement. These dizziness features of VM actually resemble the symptoms of Persistent Postural-Perceptual Dizziness diagnosis from the ICD-11, though the association of both disorders remains unknown.
Dizziness and postural imbalance symptoms without concurrent headache attacks were reported by 24.8% of our patients. Isolated vestibular symptoms were already defined in VM [5, 12, 16] . Isolated vestibular symptoms may be explained by the fact that migrainerelated neurophysiological alterations also occur during the prodromal and postdrome phases. It was notable that few patients focused only on the dizziness symptoms and denied any significant headache in the first admission to the headache unit. The existence of typical migraine associates such as photophobia and osmophobia, in addition to trigger points and tenderness over GONs and pericranial muscle tenderness, suggested migraine headache.
Vestibular-suppressant medications did not seem to ameliorate vestibular symptoms in VM. Unresponsiveness to vestibular suppressants strengthened the exclusion of peripheral vertigo because it is known that vestibular testing by itself is not 100% sensitive to rule out peripheral causes of vertigo. Some patients reported relief of vestibular symptoms by triptans and analgesics when they had isolated vertigo/dizziness episodes. VM attacks are induced by common migraine triggers, and comorbid disorders are similar to other migraine subtypes. Another remarkable point is that vestibular symptoms in migraine responded rapidly to typical migraine-preventive medications. In our patients, propranolol, duloxetine, and topiramate were the most common medications used in the treatment of VM.
Vestibular-sensitive neurons are multimodal sensory neurons [17, 18] , reacting also to other sensory modalities such as proprioception or visual motion. Vestibular information, along with somatosensory and/or visual inputs, is relayed through ventral posterolateral, ventral posteromedial, ventral posterior inferior thalamic nuclei and lateral geniculate nucleus. [19] [20] [21] . There is no identified primary vestibular cortex, and vestibular signals are widely projected to the cerebral cortex [17, 22] . Polymodal association areas in parietal, temporal, and insular cortices [23] [24] [25] and cortical areas engaged in spatial orientation (e.g., primary somatosensory cortex, primary visual cortex) are implicated in the processing of vestibular information. It is plausible to suggest that migraine patients may suffer from vestibular symptoms when the integration of visual, vestibular, and somatosensory stimuli and/or processing of one of these three components is impaired. As a matter of fact, a central interruption in the processing of the latter component during the migraine attack period was recently identified [26] [27] [28] [29] . The extent of such impairment in the processing of the visual or vestibular system remains unclear in VM.
The main limitations of the study are the retrospective review of the patients and the inadequate assessment of early responses to antimigraine treatment. The strengths of the study are that 1) it was conducted in a relatively large number of patients; 2) the patients enrolled in the study were a subgroup of VM patients who were referred to the headache unit after exclusion of peripheral causes of vertigo by an otolaryngology expert; and 3) the patients were evaluated by a headache specialist using a structured questionnaire for vestibular symptoms and headache.
In conclusion, we were able to identify the following aspects in VM patients: 1) The vestibular symptoms mainly consist of dizziness and postural imbalance. 2) Even though the total period of vestibular symptoms is long, it actually consists of brief attacks recurring with every head and body motion. 3) Short-lasting dizziness attacks and their predominance (60%) in vestibular symptoms may be included in the main VM diagnostic criteria in ICHD. 4) Visual and postural motion-induced vestibular symptoms precipitated by typical migraine triggers and unresponsive to vestibular-suppressant agents are suggestive of VM. 5) Recognition of these typical vestibular symptoms by neurologists and ear, nose, and throat specialists would avoid the delay in the diagnosis of VM.
Vestibular symptoms in our VM patients mainly consisted of brief dizziness attacks, possibly as a result of dysmodulation in multimodal sensory integration. We recently demonstrated that the central integration of somatosensory stimuli was remarkably disrupted during migraine attacks. Based on these studies [26] [27] [28] , we hypothesize that similar disruption may also occur in the integration of inputs from other sensory modalities. As vestibular symptoms are evoked upon visual and postural motion, central integration and processing of somatosensory, vestibular, and visual stimuli may be interrupted during migraine attacks. Further studies are required to elucidate this hypothesis.
